Latest Period
Q1 2026
Security Snapshot
Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA) Institutional Ownership
CUSIP: 68062P106
13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026
Institutions Reporting
193
Shares (Excl. Options)
101,411,965
Price
$14.91
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Symbol
- OLMA on Nasdaq
- Shares outstanding
- 91,696,172
- Reported price per share
- $13.97
- Price from insider filings
- $13.97
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 101,411,965
- Total reported value
- $1,511,791,720
- Portfolio coverage rank
- 0%
- Share change
- +9,862,300
- Value change
- +$99,306,003
- Number of holders
- 193
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- OLMA - Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 68062P106.
- 193 institutions reported positions in Q1 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 198 to 193 between Q4 2025 and Q1 2026.
- Reported value moved from $2,267,572,776 to $1,511,791,720.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 193 institutions filings for Q1 2026.
Security key
68062P106
Latest holder period
Q1 2026
13F holders
193
13D/G owners
7
CIK / CUSIP context first
Open Q1 2026 holders
OLMA full holder history
Olema Pharmaceuticals, Inc. SEC filings
Olema Pharmaceuticals, Inc. company facts
Olema Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 68062P106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
OLMA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 12% | +103% | $250,051,474 | +$124,423,925 | 9,998,060 | +99% | FMR LLC | 27 Feb 2026 |
| Bain Capital Life Sciences Opportunities IV, L.P. | 8.2% | -18% | $111,425,979 | -$15,437,859 | 7,473,238 | -12% | Bain Capital Life Sciences Opportunities IV, L.P. | 31 Mar 2026 |
| Paradigm Biocapital Advisors LP | 10% | $37,443,949 | 7,429,355 | Paradigm BioCapital Advisors LP | 31 Dec 2024 | |||
| JANUS HENDERSON GROUP PLC | 8.2% | -2.5% | $105,987,556 | +$5,938,564 | 7,108,488 | +5.9% | JANUS HENDERSON GROUP PLC | 31 Mar 2026 |
| Invus Global Management, LLC | 5.1% | $108,693,078 | 4,461,949 | Raymond Debbane | 16 Mar 2026 | |||
| Logos Global Management LP | 4.7% | $16,172,730 | 3,208,875 | Logos Global Management LP | 18 Mar 2025 | |||
| Point72 Asset Management, L.P. | 2.3% | $7,781,412 | 1,543,931 | Point72 Asset Management, L.P. | 31 Mar 2025 |
As of 31 Mar 2026, 193 institutional investors reported holding 101,411,965 shares of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA). This represents 111% of the company’s total 91,696,172 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
90%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 11% | 10,386,845 | +107% | 0.01% | $154,867,859 |
| Paradigm Biocapital Advisors LP | 8.7% | 8,020,576 | +6.3% | 2.4% | $119,586,788 |
| Bain Capital Life Sciences Investors, LLC | 8.1% | 7,473,238 | -12% | 10% | $111,425,979 |
| JANUS HENDERSON GROUP PLC | 7.8% | 7,108,488 | +5.9% | 0.05% | $106,013,431 |
| BlackRock, Inc. | 6.2% | 5,652,135 | +1.6% | 0% | $84,273,331 |
| BVF INC/IL | 5.8% | 5,295,893 | 0% | 2.5% | $78,961,765 |
| Siren, L.L.C. | 5.2% | 4,756,949 | +44% | 2% | $70,926,110 |
| STATE STREET CORP | 4.3% | 3,937,831 | +109% | 0% | $58,713,060 |
| Cormorant Asset Management, LP | 4.3% | 3,900,000 | +42% | 2.9% | $58,149,000 |
| Logos Global Management LP | 3.5% | 3,208,875 | 0% | 2.5% | $47,844,326 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 3,083,517 | 0% | 0% | $45,975,238 |
| RA CAPITAL MANAGEMENT, L.P. | 2.8% | 2,600,000 | 0% | 0.41% | $38,766,000 |
| JENNISON ASSOCIATES LLC | 2% | 1,822,123 | +89% | 0.02% | $27,167,854 |
| Polar Capital Holdings Plc | 1.7% | 1,602,970 | +16% | 0.1% | $23,900,283 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 1,544,417 | +23% | 0% | $23,031,429 |
| Defilade Capital Management, L.P. | 1.6% | 1,504,536 | +22% | 3.4% | $22,432,632 |
| Woodline Partners LP | 1.6% | 1,482,030 | +0.01% | 0.08% | $22,097,067 |
| LIGHTSPEED MANAGEMENT COMPANY, L.L.C. | 1.5% | 1,355,299 | -30% | 2% | $20,207,508 |
| FRANKLIN RESOURCES INC | 1.3% | 1,218,957 | -51% | 0% | $18,174,649 |
| MORGAN STANLEY | 1.3% | 1,215,690 | +83% | 0% | $18,125,938 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.3% | 1,182,836 | +7.9% | 0% | $17,637,000 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 1,169,421 | +197% | 0.01% | $17,436,067 |
| DIMENSIONAL FUND ADVISORS LP | 1.2% | 1,082,434 | +13% | 0% | $16,133,813 |
| GOLDMAN SACHS GROUP INC | 1.1% | 1,045,589 | +28% | 0% | $15,589,732 |
| Duquesne Family Office LLC | 1.1% | 986,827 | 0.5% | $14,714,000 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 101,411,965 | $1,511,791,720 | +$99,306,003 | $14.91 | 193 |
| 2025 Q4 | 90,695,275 | $2,267,572,776 | +$591,383,435 | $25.00 | 198 |
| 2025 Q3 | 68,238,531 | $668,036,044 | -$3,229,086 | $9.79 | 124 |
| 2025 Q2 | 70,511,948 | $300,429,144 | +$22,565,282 | $4.26 | 120 |
| 2025 Q1 | 65,888,228 | $247,927,417 | -$30,654,965 | $3.76 | 131 |
| 2024 Q4 | 71,278,859 | $415,382,388 | +$48,509,843 | $5.83 | 154 |
| 2024 Q3 | 58,658,581 | $700,332,942 | +$12,555,131 | $11.94 | 129 |
| 2024 Q2 | 57,896,539 | $626,445,097 | +$18,080,243 | $10.82 | 127 |
| 2024 Q1 | 56,110,675 | $635,162,151 | +$37,635,929 | $11.32 | 125 |
| 2023 Q4 | 51,618,204 | $717,066,039 | +$56,526,765 | $14.03 | 113 |
| 2023 Q3 | 47,322,813 | $584,436,985 | +$135,063,720 | $12.35 | 97 |
| 2023 Q2 | 36,408,086 | $328,764,561 | +$43,216,272 | $9.03 | 86 |
| 2023 Q1 | 33,447,196 | $116,103,891 | +$1,469,913 | $3.47 | 65 |
| 2022 Q4 | 33,334,567 | $81,640,055 | -$481,138 | $2.45 | 66 |
| 2022 Q3 | 33,359,693 | $92,063,140 | -$4,143,577 | $2.76 | 67 |
| 2022 Q2 | 34,202,982 | $139,234,855 | -$8,391,103 | $4.07 | 70 |
| 2022 Q1 | 36,374,849 | $155,206,361 | -$17,958,891 | $4.26 | 86 |
| 2021 Q4 | 38,428,075 | $359,510,482 | -$41,441,250 | $9.36 | 94 |
| 2021 Q3 | 36,741,334 | $1,012,524,920 | -$19,680,898 | $27.56 | 75 |
| 2021 Q2 | 37,428,321 | $1,047,268,923 | +$59,576,299 | $27.98 | 68 |
| 2021 Q1 | 35,240,926 | $1,158,274,244 | -$1,710,105 | $33.18 | 73 |
| 2020 Q4 | 35,073,865 | $1,657,230,008 | +$1,657,206,010 | $48.08 | 56 |